The effect of montelukast (10 mg daily) and loratadine (10 mg daily) on wheal, flare and itching reactions in skin prick tests

Pulmonary Pharmacology and Therapeutics

Volumn 20, Issue 1, 2007, Pages 85-89

  Kupczyk, Maciej ^a   Kupryś, Izabela ^a   Górski, Paweł ^a   Kuna, Piotr ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Allergy diagnosis; Montelukast; Skin prick tests

Indexed keywords

ALLERGEN; CODEINE; HISTAMINE; LACTOSE; LORATADINE; MONTELUKAST; PLACEBO; ACETIC ACID DERIVATIVE; ANTIPRURITIC AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; QUINOLINE DERIVATIVE;

ADULT; ARTICLE; ATOPY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIAGNOSTIC TEST; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GRASS; HUMAN; MALE; PRICK TEST; PRIORITY JOURNAL; PRURITUS; RANK SUM TEST; SKIN TEST; STATISTICAL SIGNIFICANCE; URTICARIA; IMMUNOLOGY; INSTRUMENTATION; METHODOLOGY; MICROCAPSULE; POLLEN; SKIN; STANDARD; TIME; TREATMENT OUTCOME;

ACETATES; ALLERGENS; ANTIPRURITICS; CAPSULES; CODEINE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HISTAMINE; HUMANS; LEUKOTRIENE ANTAGONISTS; LORATADINE; MALE; POLLEN; PRURITUS; QUINOLINES; SKIN; SKIN TESTS; TIME FACTORS; TREATMENT OUTCOME; URTICARIA;

EID: 33750465885     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2005.12.010     Document Type: Article

References (28)

1. Bousquet J., and Michel F.B. Precision of prick and puncture tests. J Allergy Clin Immunol 90 (1992) 870-872
2. Nelson H.S., Lahr J., Buchmeier A., et al. Evaluation of devices for skin prick testing. J Allergy Clin Immunol 101 (1998) 153-156
3. Berkowitz R.B., Tinkelman D.G., Lutz C., et al. Evaluation of the Multi-Test device for immediate hypersensitivity skin testing. J Allergy Clin Immunol 90 (1992) 979-985
4. Des Roches A., Paradis L., Bougeard Y.H., et al. Long term oral corticosteroid therapy does not alter the results of immediate-type allergy skin prick tests. J Allergy Clin Immunol 98 (1996) 522-527
5. Engler D.B., De Jarnatt A.C., Sim T.C., et al. Comparison of the sensitivity and precision of four skin test devices. J Allergy Clin Immunol 90 (1992) 985-991
6. 4) in human skin. J Invest Dermatol 80 2 (1983) 115-119
7. 4 and histamine in human allergic skin reactions. J Clin Invest 76 2 (1985) 650-656
8. Kupczyk M., Kupryś I., Górski P., and Kuna P. Not one lancet for multiple SPT. Allergy 56 (2001) 256-257
9. Allergen standarisation and skin tests. Position paper. Allergy 48 Suppl. 14 (1993) 48-82
10. Dreborg S., and Frew A. Skin test used in type I allergy testing. Position paper of the European Academy of Allergology and Clinical Immunology. Allergy 44 Suppl. 10 (1989) 1-59
11. Illi S., Garcia-Marcos L., Hernando V., et al. Reproducibility of skin test results in epidemiologic studies: a comparison of two devices. Allergy 53 (1998) 353-358
12. 4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol 84 1 (1989) 19-26
13. 4 levels after allergen and exercise challenge in bronchial asthma. Am Rev Respir Dis 144 6 (1991) 1411-1413
14. 4 during aspirin-induced asthma. J Lab Clin Med 119 1 (1992) 48-51
15. Spector S.L., and Tan R.A. Effectiveness of montelukast in the treatment of cough variant asthma. Ann Allergy Asthma Immunol 93 3 (2004) 232-236
16. Kurowski M., Kuna P., and Gorski P. Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation. Allergy 59 3 (2004) 280-288
17. Di Lorenzo G., Pacor M.L., Mansueto P., et al. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. J Allergy Clin Immunol 114 3 (2004) 619-625
18. 4 in humans. J Lab Clin Med 108 1 (1986) 70-75
19. 4. Br J Pharmacol 80 3 (1983) 497-502
20. 4 in patients with chronic idiopathic urticaria and in normal subjects. J Allergy Clin Immunol 86 5 (1990) 759-765
21. 4 in human skin. J Invest Dermatol 88 2 (1987) 109-114
22. Bisgaard H., Lerche A., and Kristensen J.K. Leukotriene- and histamine-induced increases in vascular permeability and interstitial transport in the skin. J Invest Dermatol 84 5 (1985) 427-429
23. 4 on cutaneous blood flow in humans. Prostaglandins 23 6 (1982) 797-801
24. 4 and histamine-induced cutaneous vascular reactions in man. J Allergy Clin Immunol 87 1 Pt 1 (1991) 93-98
25. Simons F.E., Johnston L., Gu X., et al. Suppression of the early and late cutaneous allergic responses using fexofenadine and montelukast. Ann Allergy Asthma Immunol 86 1 (2001) 44-50
26. Hill III S.L., and Krouse J.H. The effects of montelukast on intradermal wheal and flare. Otolaryngol Head Neck Surg 129 3 (2003) 199-203
27. Jackson C.M., Lee D.K., and Lipworth B.J. The effects of butterbur on the histamine and allergen cutaneous response. Ann Allergy Asthma Immunol 92 2 (2004) 250-254
28. Sekerel B.E., and Akpinarli A. The effect of montelukast on allergen-induced cutaneous responses in house dust mite allergic children. Pediatr Allergy Immunol 14 3 (2003) 212-215